相似文献
1
Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease.
Chem Soc Rev. 2014 Oct 7;43(19):6692-700. doi: 10.1039/c3cs60431d.
2
Physicochemical interactions of amyloid beta-peptide with lipid bilayers.
Biochim Biophys Acta. 2007 Aug;1768(8):1935-42. doi: 10.1016/j.bbamem.2007.02.009. Epub 2007 Feb 20.
3
Aggregation of Alzheimer's amyloid β-peptide in biological membranes: a molecular dynamics study.
Biochemistry. 2013 Jul 23;52(29):4971-80. doi: 10.1021/bi400562x. Epub 2013 Jul 15.
4
Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
Biochemistry. 2014 Jul 22;53(28):4489-502. doi: 10.1021/bi500373k. Epub 2014 Jul 11.
5
How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Acc Chem Res. 2014 Aug 19;47(8):2397-404. doi: 10.1021/ar500127z. Epub 2014 Jul 16.
6
Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.
Neurochem Res. 2004 Dec;29(12):2267-72. doi: 10.1007/s11064-004-7035-1.
7
Effect of the surface charge of artificial model membranes on the aggregation of amyloid β-peptide.
Biochimie. 2012 Aug;94(8):1730-8. doi: 10.1016/j.biochi.2012.03.027. Epub 2012 Apr 20.
8
Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity.
J Biol Chem. 1996 Oct 25;271(43):26482-9. doi: 10.1074/jbc.271.43.26482.
9
Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.
Chem Soc Rev. 2014 Oct 7;43(19):6750-64. doi: 10.1039/c3cs60459d.
10
The Role of Amyloid β-Biomembrane Interactions in the Pathogenesis of Alzheimer's Disease: Insights from Liposomes as Membrane Models.
Chemphyschem. 2021 Aug 4;22(15):1547-1565. doi: 10.1002/cphc.202100124. Epub 2021 Jun 29.
引用本文的文献
1
Effect of Tau Fragment and Membrane Interactions on Membrane Permeabilization and Peptide Aggregation.
Membranes (Basel). 2025 Jul 13;15(7):208. doi: 10.3390/membranes15070208.
2
An O-glycopeptide participates in the formation of distinct Aβ fibril structures and attenuates Aβ neurotoxicity.
Nat Commun. 2025 Jul 1;16(1):5815. doi: 10.1038/s41467-025-60978-w.
3
Ceramide: a central regulator in Alzheimer's disease pathogenesis.
Inflammopharmacology. 2025 Apr;33(4):1775-1783. doi: 10.1007/s10787-025-01719-9. Epub 2025 Mar 27.
4
Anionic lipid catalyzes the generation of cytotoxic insulin oligomers.
bioRxiv. 2025 Jan 18:2025.01.14.633028. doi: 10.1101/2025.01.14.633028.
5
In the Beginning: Let Hydration Be Coded in Proteins for Manifestation and Modulation by Salts and Adenosine Triphosphate.
Int J Mol Sci. 2024 Nov 28;25(23):12817. doi: 10.3390/ijms252312817.
6
Amyloid-β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects.
Ibrain. 2024 May 23;10(3):266-289. doi: 10.1002/ibra.12155. eCollection 2024 Fall.
7
Novel combination of Olesoxime/Resveratrol-encapsulated exosomes to improve cognitive function by targeting amyloid β-induced Alzheimer's disease: investigation on in vitro and in vivo model.
Inflammopharmacology. 2024 Aug;32(4):2613-2628. doi: 10.1007/s10787-024-01476-1. Epub 2024 May 16.
8
HuM195 and its single-chain variable fragment increase Aβ phagocytosis in microglia via elimination of CD33 inhibitory signaling.
Mol Psychiatry. 2024 Jul;29(7):2084-2094. doi: 10.1038/s41380-024-02474-z. Epub 2024 Feb 21.
9
A β-barrel-like tetramer formed by a β-hairpin derived from Aβ.
Chem Sci. 2023 Nov 28;15(1):285-297. doi: 10.1039/d3sc05185d. eCollection 2023 Dec 20.
10
Spike Protein Fragments Promote Alzheimer's Amyloidogenesis.
ACS Appl Mater Interfaces. 2023 Aug 30;15(34):40317-40329. doi: 10.1021/acsami.3c09815. Epub 2023 Aug 16.
本文引用的文献
1
On the subject of rigor in the study of amyloid β-protein assembly.
Alzheimers Res Ther. 2013 Aug 27;5(4):39. doi: 10.1186/alzrt203. eCollection 2013.
2
2D 1H/1H RFDR and NOESY NMR experiments on a membrane-bound antimicrobial peptide under magic angle spinning.
J Phys Chem B. 2013 Jun 6;117(22):6693-700. doi: 10.1021/jp4034003. Epub 2013 May 21.
3
2013 Alzheimer's disease facts and figures.
Alzheimers Dement. 2013 Mar;9(2):208-45. doi: 10.1016/j.jalz.2013.02.003.
4
Alzheimer's disease: which type of amyloid-preventing drug agents to employ?
Phys Chem Chem Phys. 2013 Jun 21;15(23):8868-77. doi: 10.1039/c3cp00017f. Epub 2013 Feb 28.
5
Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity.
PLoS One. 2012;7(10):e47261. doi: 10.1371/journal.pone.0047261. Epub 2012 Oct 15.
6
Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation.
Biochemistry. 2012 Oct 2;51(39):7676-84. doi: 10.1021/bi3009888. Epub 2012 Sep 21.
7
Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation.
Biophys J. 2012 Aug 22;103(4):702-10. doi: 10.1016/j.bpj.2012.06.045.
8
The polyphenol EGCG inhibits amyloid formation less efficiently at phospholipid interfaces than in bulk solution.
J Am Chem Soc. 2012 Sep 12;134(36):14781-8. doi: 10.1021/ja3031664. Epub 2012 Aug 27.
9
Clinical and biomarker changes in dominantly inherited Alzheimer's disease.
N Engl J Med. 2012 Aug 30;367(9):795-804. doi: 10.1056/NEJMoa1202753. Epub 2012 Jul 11.
10
Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity.
J Biol Chem. 2012 Jul 13;287(29):24765-73. doi: 10.1074/jbc.M111.329763. Epub 2012 Apr 30.
Zotero 插件